Movement Alert｜METIS TECHBIO-P Intraday Rise 7.6% in Regular Trading, AI drug discovery sentiment and biotech strength support rebound

Market Focus10-16

On October 16, METIS TECHBIO-P recorded an Intraday Rise of 7.6% in Regular Trading, trading at HK$11.77, with turnover of HK$10.60 million.

The move coincided with a broader rebound in Hong Kong biotech and AI drug discovery names. Recent market coverage indicated that biotech shares turned stronger, helping lift sentiment in AI drug discovery stocks and supporting a rebound in METIS TECHBIO-P.

Background fundamentals remain improved. The company previously reported interim revenue of RMB154 million, up 13,399% year over year, while adjusted net loss narrowed 56.4% to RMB51 million. The stock was also added to the Stock Connect universe in September, and management commentary and prior reports pointed to continued commercialization progress from its NanoForge platform, which has helped underpin investor confidence during sector swings.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment